Iomai Announces Data from Phase 2 Field Study of Travelers' Diarrhea Vaccine Accepted for Presentatio... ( GAITHERSBURG Md. Aug. 23 /- Iomai...)

Iomai Announces Data from Phase 2 Field Study of Travelers' Diarrhea Vaccine Accepted for Presentation at ICAAC

Date:8/23/2007

GAITHERSBURG, Md., Aug. 23 /PRNewswire-FirstCall/ -- Iomai Corporation (Nasdaq: IOMI) today announced that the abstract detailing efficacy and safety results from its double-blind Phase 2 field study of a patch-based vaccine for travelers' diarrhea has been accepted as a "late breaker" presentation at Interscience Conference on Antimicrobials and Chemotherapy (ICAAC), to be held in Chicago Sept. 17 to 20.

The abstract, "Transcutaneous Immunization with the Heat Labile Toxin (LT) of Enterotoxigenic Escherichia coli (ETEC) Protects in a Phase 2 Field Trial in Travelers to Guatemala and Mexico," will be presented by Gregory Glenn, M.D., Iomai's chief scientific officer, on Tuesday, Sept. 18, during the session on "Vaccines and Pediatric Infections." The session will be held from 1:30 to 4 p.m.

About Travelers' Diarrhea

This year, approximately 55 million international travelers will visit countries where bacteria that cause travelers' diarrhea are endemic, particularly Africa, Asia and Latin America, and about 20 million of those travelers will develop travelers' diarrhea.

Travelers' diarrhea (TD) is caused by ingestion of pathogens in contaminated food and water. Of the 54 million travelers to endemic areas, an estimated 17 million will contract TD, making it one of the most common illnesses in travelers. Symptoms last for 3 to 5 days, and 55 percent of subjects who become ill have more than six stools daily, with an average of 18 total stools per episode. TD is often accompanied by nausea, vomiting and cramping and can result in severe dehydration, mimicking the symptoms of cholera. Although generally self-limited, TD is often accompanied by prostration and can require hospitalization, often in
'/>"/>

SOURCE Iomai Corporation
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related medicine technology :

1. Iomai to Announce Results From Phase 1 Influenza Trial and Host Webcast Tomorrow
2. Iomai Dose-Ranging Trial Demonstrates Needle-Free Patch Vaccine for Travelers Diarrhea Stimulates Immune Response Even at Low Doses
3. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
4. Sygnis Pharma AG announces date for presentation of clinical results
5. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
6. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
7. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
8. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
9. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
10. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
11. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease

Post Your Comments:

(Date:5/24/2013)... 2013 /PRNewswire-iReach/ -- Phoenix Houses of California ... organization, is hosting its tenth annual "Triumph For Teens" ... 6, 2013. More than 300 people are expected to ... residential treatment centers, family therapy, and prevention programs of ... have positive influences on the health and welfare of our ...

(Date:5/24/2013)... -- An international roster of experts on malignant pleural mesothelioma ... Santa Monica, Calif. , to discuss their latest ... rare form of cancer that results from exposure to ... the chest. Hosted by UCLA and the ... International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma ...

(Date:5/24/2013)... China Biologic Products, Inc. (Nasdaq: CBPO, "China Biologic" or ... in China , today announced that ... issued by Shanghai RAAS Blood Products Co., Ltd. ("Shanghai ... that on May 21, 2013, Ms. Siu ... shareholders of the Company, and her spouse, Mr. Tung ...

Breaking Medicine Technology:Phoenix House Honors Allergan Chairman David Pyott And Legendary Sports Agent And Humanitarian, Leigh Steinberg 2 Phoenix House Honors Allergan Chairman David Pyott And Legendary Sports Agent And Humanitarian, Leigh Steinberg 3 International Mesothelioma Experts Present Promising New Research Findings at the 3rd Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma 2 International Mesothelioma Experts Present Promising New Research Findings at the 3rd Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma 3 China Biologic Comments on the Proposed Shanghai RAAS Transaction 2 China Biologic Comments on the Proposed Shanghai RAAS Transaction 3 China Biologic Comments on the Proposed Shanghai RAAS Transaction 4

[0] Phoenix House Honors Allergan Chairman David Pyott And Legendary Sports Agent And Humanitarian, Leigh Steinberg [0] International Mesothelioma Experts Present Promising New Research Findings at the 3rd Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma [0] China Biologic Comments on the Proposed Shanghai RAAS Transaction

... Aug. 3, 2011 Reportlinker.com ... research report is available in ... China Orthopedic Devices Market Outlook ... Spinal Surgery, Orthobiologics, Trauma Fixation ...

... the nationally-accredited home healthcare provider and manufacturer of the ... a federal supply contract to offer their portable oxygen ... the Department of Veterans Affairs (VA). This ... to the VA and all other federal government agencies ...

China Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others Inogen Awarded Department of Veterans Affairs Contract

(Date:5/25/2013)... According to a new market report,"Global ... by MarketsandMarkets is expected to reach $544.02 Billion ... analyzes and studies the major market drivers, restraints, ... Rest of the World. , Browse:, ... 87 Figures , 175 Pages ...

(Date:5/25/2013)... Vancouver, BC (PRWEB) May 25, 2013 ... of the most beautiful and powerful women that ever ... was felt by some of the most powerful men ... used many beauty remedies to keep her skin glowing ... treatments made with bees- wax, maringa oil and cyprus ...

(Date:5/25/2013)... Angeles, CA (PRWEB) May 25, 2013 IBISWorld ... will grow at an average annual rate of 28.7% to ... of 17.9% in 2013. From 2002 and 2008, no new ... Kevin Culbert, causing relatively modest growth during that period. In ... has approved six new products. This factor contributed to the ...

(Date:5/25/2013)... Ayurveda is the traditional medicine of India. Ayurveda ... medical science, its scope enters into the realms of the ... that disease is the end result of living out of ... one must discover where we are living out of harmony ... into perfect harmony. , The Foundations course in Mexico ( ...

(Date:5/25/2013)... Arizona (PRWEB) May 25, 2013 The current ... Center, their parents, and the B2B staff all came together ... everyone enjoyed an array of Indian Cuisine, the residents got ... company, for helping them on their road to recovery, and ... the Drug and Alcohol center in 2010 after realizing the ...

Breaking Medicine News(10 mins):Health News:Homeland Security Market to Reach $544.02 Billion by 2018 at a CARC of 5.54% - New Report by MarketsandMarkets 2 Health News:Homeland Security Market to Reach $544.02 Billion by 2018 at a CARC of 5.54% - New Report by MarketsandMarkets 3 Health News:Homeland Security Market to Reach $544.02 Billion by 2018 at a CARC of 5.54% - New Report by MarketsandMarkets 4 Health News:The Cleopatra Lift - A New Non Surgical Option to Aging Offered by Vancouver Physician 2 Health News:The Cleopatra Lift - A New Non Surgical Option to Aging Offered by Vancouver Physician 3 Health News:Slow Healing: Cell Therapy in the US Industry Market Research Report Now Available from IBISWorld 2 Health News:Slow Healing: Cell Therapy in the US Industry Market Research Report Now Available from IBISWorld 3 Health News:Fundamentos de Ayurveda in Mexico (Ayurvedic Principles) Offered by Escuela de Ayurveda de California 2 Health News:Back2Basics Drug and Alcohol Rehabilitation Center Celebrates Their 3rd Anniversary 2

[0] Homeland Security Market to Reach $544.02 Billion by 2018 at a CARC of 5.54% - New Report by MarketsandMarkets [0] The Cleopatra Lift - A New Non Surgical Option to Aging Offered by Vancouver Physician [0] Slow Healing: Cell Therapy in the US Industry Market Research Report Now Available from IBISWorld [0] Fundamentos de Ayurveda in Mexico (Ayurvedic Principles) Offered by Escuela de Ayurveda de California [0] Back2Basics Drug and Alcohol Rehabilitation Center Celebrates Their 3rd Anniversary

... Rajasthan is to unveil an ambitious roadmap to boost medical ... will have to cough up //at least Rs.50 million (a ... ,Education Minister Ghanshyam Tiwari will unveil the "Policy to Promote ... Association of North America (RANA) conference in New York July ...

... New York, A scientific discovery that has helped rats ... the surface of brain cells has rejuvenated hopes about ... severe injuries such as stroke or spinal-cord damages. ... it could be possible to provoke the body's own ...

... an entire tier of the NHS in England was ... multinational firms to manage services worth up to ?64bn. ... in the EU official journal inviting companies to begin ... the purchasing of healthcare for millions of NHS patients. ...

... was announced that patients who are in need of cardiac//, ... for more than six months. ,The British ... and federal medical associations. Long waits result in further deterioration ... ,These then result in an increase in ...

... drug which is claimed to be very effective in treating ... FDA //but is thought to replace another proven and cost ... already called the wonder drug. AMD is a chronic ... of blindness in the country. ,Dr. Philip Rosenfeld, ...

... short-term solutions a trade union has launched a scathing attack ... one in five graduating student nurses would be employed. ... overseas to meet workforce targets because of shortage of qualified ... job once they qualify after three years of study. ...

Cached Medicine News:Health News:Nurses Face Unemployment 2

Rajasthan Plans to Promote Medical Tourism and Medical Education in the State New discovery may help treat stroke-affected humans Privatization Plan of NHS Health Care Revealed B C Medical Association Reports on Setting Limits to Waiting Times Latest Drug for AMD, Beyond The Reach Of Common Man Nurses Face Unemployment

... is an easy-to-use, automated system that enables ... assays for managing hemostatic disordersincluding D-Dimer, Von ... offers reflex and rerun testing for greater ... by our high-quality service to help your ...

... Predictable Protection Made Easy. The new generation ... effectiveness and ease of use, providing you ... SVG stenting and angioplasty procedures., ,The FilterWire ... while requiring minimal changes to technique. ...

Representing the next step in the evolution of point-of-care testing, the i-STAT 1 Analyzer uses one platform to perform glucose strip testing along with all i-STAT test cartridges....

... 4194 Bipolar over-the-wire left-heart lead is for ... steroid-eluting lead has an angled shape and ... or a stylet delivery method, giving physicians ... position the lead in a variety of ...

Medicine Products:

ACL 8000 FilterWire EZ Embolic Protection System i-STAT 1 Attain OTW Model 4194 Bi-Polar